Dr. Jeffrey Bluestone is the CEO and President of Sonoma Biotherapeutics, a San Francisco and Seattle-based company leveraging the properties of regulatory T cells to create living cell therapies that restore the immune system back to its balanced, fully functioning state.
Read More
Dr. Marc Jenkins is a Regents and Distinguished McKnight University Professor in the Department of Microbiology and Immunology and the Director of the Center for Immunology at the University of Minnesota. Dr. Jenkins discovered that CD4+ T cells require CD28 as well as TCR to produce IL-2. The Jenkins lab is focused on the basic biology of CD4+ T lymphocytes.
Read More
Dr. Isaac Chiu is an Assistant Professor of Immunology at Harvard Medical School, studying the role of the nervous system in mediating inflammation and host defense. Dr. Tiphaine Voisin is a Postdoctoral Fellow at Harvard Medical School, specializing in somato-sensation and neuro-immunology. They recently published a paper in PNAS on the role of the CysLT2R receptor in acute and chronic itch.
Read More
Drs. Mindy, Amy, and Kristen Engevik are sisters and immunologists. Mindy and Amy are Assistant Professors at the Medical University of South Carolina and Kristen is a Postdoctoral Fellow at Baylor College of Medicine.
Read More
Dr. Filipe Pereira is an Associate Professor at the Lund Stem Cell Center at Lund University. The Pereira lab studies how hematopoietic cell fate is specified, maintained, and eventually modified or reversed. Inspired by the fields of stem cell biology, immunology, and cancer, they use an interdisciplinary approach to mechanistically understand hematopoietic and immune cell identities and translate their findings into novel gene and cell therapies.
Read More